ProShare Advisors LLC Buys 19,356 Shares of Oscar Health, Inc. (NYSE:OSCR)

ProShare Advisors LLC increased its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 52.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 56,098 shares of the company's stock after buying an additional 19,356 shares during the period. ProShare Advisors LLC's holdings in Oscar Health were worth $754,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Summit Investment Advisors Inc. boosted its position in Oscar Health by 5.8% during the fourth quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock worth $280,000 after purchasing an additional 1,141 shares during the period. Arizona State Retirement System boosted its position in Oscar Health by 3.1% during the fourth quarter. Arizona State Retirement System now owns 47,918 shares of the company's stock worth $644,000 after purchasing an additional 1,454 shares during the period. Xponance Inc. boosted its position in Oscar Health by 12.9% during the fourth quarter. Xponance Inc. now owns 14,394 shares of the company's stock worth $193,000 after purchasing an additional 1,649 shares during the period. KBC Group NV boosted its position in Oscar Health by 56.1% during the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after purchasing an additional 2,555 shares during the period. Finally, Alliancebernstein L.P. boosted its position in Oscar Health by 1.1% during the fourth quarter. Alliancebernstein L.P. now owns 243,160 shares of the company's stock worth $3,268,000 after purchasing an additional 2,600 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Insider Activity

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of Oscar Health stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director now directly owns 64,512 shares in the company, valued at $1,059,932.16. The trade was a 27.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 24.39% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of brokerages have weighed in on OSCR. Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and cut their target price for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Wall Street Zen lowered shares of Oscar Health from a "buy" rating to a "hold" rating in a research report on Thursday, May 22nd. Two research analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $20.08.

Oscar Health Price Performance

Shares of OSCR stock traded down $1.09 during trading hours on Wednesday, reaching $13.92. The stock had a trading volume of 9,996,630 shares, compared to its average volume of 4,349,700. The stock's fifty day simple moving average is $13.73 and its 200 day simple moving average is $14.59. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.79. The firm has a market capitalization of $3.49 billion, a PE ratio of -695.65 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company had revenue of $3 billion during the quarter, compared to analyst estimates of $2.87 billion. During the same period last year, the business earned $0.62 earnings per share. Oscar Health's revenue was up 42.2% compared to the same quarter last year. On average, equities research analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.